OMB APPROVAL
--------------------------
OMB Number: 3235-0059
Expires: July 31, 2004
Estimated average burden
hours per response...14.73
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
SCHEDULE 14A
----------
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant: [X]
Filed by a Party other than the Registrant: [ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement.
[ ] CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY
RULE 14a-6(e)(2)).
[X] Definitive Proxy Statement.
[ ] Definitive Additional Materials.
[ ] Soliciting Material Pursuant to Section 240.14A-11(c) or Section 240.14a-12
CORE LABORATORIES N.V.
--------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)
--------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement if other than the Registrant)
Payment of Filing Fee (check the appropriate box):
[X] No fee required.
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
1) Title of each class of securities to which transaction applies:
--------------------------------------------------------------------------------
2) Aggregate number of securities to which transaction applies:
--------------------------------------------------------------------------------
3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
--------------------------------------------------------------------------------
4) Proposed maximum aggregate value of transaction:
--------------------------------------------------------------------------------
5) Total fee paid:
--------------------------------------------------------------------------------
[ ] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
1) Amount Previously Paid:
--------------------------------------------------------------------------------
2) Form, Schedule or Registration Statement No.:
--------------------------------------------------------------------------------
3) Filing Party:
--------------------------------------------------------------------------------
4) Date Filed:
--------------------------------------------------------------------------------
PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION CONTAINED IN THIS
FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY VALID OMB
CONTROL NUMBER.
SEC 1913 (11-01)
CORE LABORATORIES N.V.
HERENGRACHT 424
1017 BZ AMSTERDAM
THE NETHERLANDS
---------------------
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
TO BE HELD MAY 23, 2003
---------------------
Dear Shareholder:
You are cordially invited to attend our 2003 annual meeting of shareholders
which will be held at the law offices of Nauta Dutilh, Prinses Irenestraat 59,
1077 WV, Amsterdam, The Netherlands, on Friday, May 23, 2003 at 10:00 a.m.,
local time, for the following purposes:
1. To elect two Class III Supervisory Directors to serve until our
annual meeting in 2006 and until their successors shall have been duly
elected and qualified;
2. To confirm and adopt our Dutch Statutory Annual Accounts for the
fiscal year ended December 31, 2002;
3. To approve the extension of the authority of our Management Board
to repurchase up to 10% of our outstanding share capital until November 22,
2004;
4. To approve the extension of the authority of our Supervisory Board
to issue and/or to grant rights (including options to purchase) with
respect to our common and preference shares until May 22, 2008;
5. To approve the extension of the authority of our Supervisory Board
to limit or exclude the preemptive rights of the holders of our common
shares until May 22, 2008;
6. To ratify the appointment of PricewaterhouseCoopers as our
company's independent public accountants for the year ended December 31,
2003; and
7. To transact such other business as may properly come before the
annual meeting or any adjournment thereof.
Each of the matters being presented at the annual meeting has been
presented to and approved by our shareholders at our prior annual meetings. In
large measure, these matters are presented to our shareholders each year as a
result of our being organized under the laws of The Netherlands. Copies of the
Annual Accounts, the report of the Management Board and the list of nominees for
the Supervisory Board are open for inspection at our offices in The Netherlands,
located at Herengracht 424, 1017 BZ Amsterdam, Attention: Mr. Jacobus Schouten,
by registered shareholders and other persons entitled to attend our shareholder
meetings. Such copies will be open for inspection from the date of this notice
until the close of our annual meeting.
IT IS IMPORTANT THAT YOUR SHARES BE REPRESENTED AT THE ANNUAL MEETING
REGARDLESS OF WHETHER YOU PLAN TO ATTEND. THEREFORE, PLEASE MARK, SIGN, DATE AND
RETURN THE ENCLOSED PROXY CARD PROMPTLY. IF YOU ARE PRESENT AT THE ANNUAL
MEETING AND WISH TO DO SO, YOU MAY REVOKE YOUR PROXY AND VOTE IN PERSON.
By Order of the Board of Supervisory
Directors,
-s- Jacobus Schouten
JACOBUS SCHOUTEN
Supervisory Director
April 30, 2003
Amsterdam, The Netherlands
CORE LABORATORIES N.V.
HERENGRACHT 424
1017 BZ AMSTERDAM
THE NETHERLANDS
---------------------
PROXY STATEMENT
---------------------
SOLICITATION AND REVOCATION OF PROXIES
The accompanying proxy is being solicited by and on behalf of the Board of
Supervisory Directors of Core Laboratories N.V. for use at our 2003 annual
meeting of shareholders to be held at the law offices of Nauta Dutilh, Prinses
Irenestraat 59, 1077 WV, Amsterdam, The Netherlands, on Friday, May 23, 2003 at
10:00 a.m., local time. If the accompanying proxy card is properly executed and
returned, the shares it represents will be voted at the annual meeting in
accordance with the directions noted on the card, or, if no directions are
indicated, it will be voted for the two nominees for Supervisory Director and in
favor of the other proposals described in this proxy statement. Any shareholder
giving a proxy has the power to revoke it (1) by giving oral or written notice
to our corporate Secretary at any time before the proxy is voted, (2) by
submitting a properly signed proxy card with a later date, or (3) by voting in
person at the annual meeting.
The solicitation of proxies by the Supervisory Board will be conducted by
mail. In addition, certain members of the Supervisory Board, officers and
regular employees of our company may solicit proxies in person, by facsimile, by
telephone or by other means of electronic communication. Core Laboratories will
bear the cost of preparing and mailing proxy materials as well as the cost of
soliciting proxies and will reimburse banks, brokerage firms, custodians,
nominees and fiduciaries for their expenses in sending proxy materials to the
beneficial owners of our common shares.
At the close of business on April 15, 2003, the record date for the
determination of shareholders entitled to notice of and to vote at our annual
meeting, there were 33,277,110 common shares outstanding, each of which is
entitled to one vote. Our common shares are the only class of our capital stock
outstanding and entitled to notice of and to vote at the annual meeting. The
presence, in person or by proxy, of at least a majority of our outstanding
common shares is required for a quorum. Under the Dutch Civil Code and our
articles of association, common shares abstaining from voting and broker
non-votes will not count as votes cast at the annual meeting but will count for
the purpose of determining whether a quorum is present at the meeting.
A copy of our Annual Report on Form 10-K for the year ended December 31,
2002, including the financial statements, schedules and exhibits thereto, may be
obtained without charge by written request to John D. Denson, Secretary, in the
care of Core Laboratories, LP, 6316 Windfern Road, Houston, Texas 77040.
This proxy statement and the accompanying proxy card were first mailed to
shareholders on or about April 30, 2003.
ITEM 1
ELECTION OF SUPERVISORY DIRECTORS
Our articles of association provide for one or more Supervisory Directors.
Our Supervisory Board currently has seven members who are divided into three
classes of Supervisory Director. Each class is elected for a term of three years
such that the term of one class of Supervisory Director expires at the annual
meeting each year. At this year's annual meeting we will be electing two Class
III Supervisory Directors whose terms expire at the annual meeting. The
Supervisory Board is proposing the election of Richard L. Bergmark and Alexander
Vriesendorp as Class III Supervisory Directors for a term expiring at the annual
meeting in 2006. Both of the nominees for Supervisory Director are presently
members of the Supervisory Board.
Nominees for Supervisory Director are proposed by our Supervisory Board and
elected at the annual meeting by the affirmative vote of a majority of the votes
cast at the meeting. Our shareholders may override the proposal of the
Supervisory Board by a vote of two-thirds of the votes cast at the meeting if
more than one-half of the outstanding share capital is present or represented.
Unless otherwise instructed or unless authority to vote is withheld, the
enclosed proxy will be voted for the election of the nominees listed above. If
at the time of, or prior to, the annual meeting any of the nominees should be
unable or decline to serve, the discretionary authority provided in the proxy
may be used to vote for a substitute or substitutes designated by our
Supervisory Board. The Supervisory Board has no reason to believe that any
substitute nominees will be required. No proxy will be voted for a greater
number of persons than the number of nominees named herein. Shareholders may not
cumulate their votes in the election of Supervisory Directors.
THE SUPERVISORY BOARD RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE NOMINEES
FOR SUPERVISORY DIRECTOR AS SET FORTH ABOVE, AND PROXIES EXECUTED AND RETURNED
WILL BE SO VOTED UNLESS CONTRARY INSTRUCTIONS ARE INDICATED THEREON.
The following table sets forth the names, ages and titles of our
Supervisory Directors whose terms expire at the annual meeting and who have been
nominated for reelection as Supervisory Director:
CLASS III SUPERVISORY DIRECTORS
(TERM TO EXPIRE 2006)
NAME AGE POSITION
---- --- --------
Richard L. Bergmark....................... 49 Executive Vice President, Chief Financial
Officer, Treasurer and Supervisory Director
Alexander Vriesendorp..................... 50 Supervisory Director
The following tables set forth the names, ages and titles of our
Supervisory Directors whose terms do not expire at the annual meeting:
CLASS I SUPERVISORY DIRECTORS
(TERM EXPIRES 2005)
NAME AGE POSITION
---- --- --------
David M. Demshur.......................... 48 Chairman of the Supervisory Board,
President and Chief Executive Officer
Rene R. Joyce............................. 55 Supervisory Director
Jacobus Schouten.......................... 48 Supervisory Director
CLASS II SUPERVISORY DIRECTORS
(TERM EXPIRES 2004)
NAME AGE POSITION
---- --- --------
D. John Ogren............................. 60 Supervisory Director
Joseph R. Perna........................... 60 Supervisory Director
Set forth below is a brief description of the business experience and
length of service of our Supervisory Directors.
Richard L. Bergmark joined Western Atlas International, Inc. as Treasurer
in 1987. From 1987 to 1994, our company was operated as a division of Western
Atlas. In 1991, Mr. Bergmark became the Area Manager for Finance and
Administration for Europe, Africa and the Middle East operations of Western
Geophysical, a
2
division of Western Atlas. From our separation with Western Atlas in 1994 until
1999, he served as our Chief Financial Officer and in 1999 he was appointed
Executive Vice President. Mr. Bergmark presently serves as our Executive Vice
President, Chief Financial Officer and Treasurer and as a Supervisory Director.
Mr. Bergmark has served as a Supervisory Director since our initial public
offering in 1995.
David M. Demshur joined our company in 1979 and presently serves as our
President, Chief Executive Officer and Chairman of our Supervisory Board. Since
joining our company, Mr. Demshur has held various operating positions, including
Manager of Geological Sciences from 1983 to 1987, Vice President of Europe,
Africa and the Middle East from 1989 to 1991, Senior Vice President of Petroleum
Services from 1991 to 1994 and Chief Executive Officer and President from 1994
to the present time. Mr. Demshur is a member of the Society of Petroleum
Engineers, the American Association of Petroleum Geologists, Petroleum
Exploration Society of Great Britain and the Society of Core Analysts Section of
the Society of Professional Well Loggers Association. Mr. Demshur has served as
a Supervisory Director since our initial public offering in 1995 and as Chairman
of the Supervisory Board since May 2001.
Rene R. Joyce served as President of Energy Services of Coral Energy, LLC
from its acquisition by Shell Oil Company in 1998 until his retirement at the
end of 1999. From 1980 until 1998, Mr. Joyce served as President of the
operating companies of Tejas Gas Corporation, Coral's predecessor and a New York
Stock Exchange listed company. Mr. Joyce is a member of the Louisiana State Bar
Association and is an independent consultant in the energy industry. Mr. Joyce
has served as a Supervisory Director since 2000.
D. John Ogren served as the President of Production Operators, Inc. from
1994 until 1999. Production Operators was listed on the Nasdaq Stock Market
prior to its acquisition by Camco International in 1997 and Schlumberger's
acquisition of Camco International in 1998. From 1989 until 1991, Mr. Ogren
served as Senior Vice President of Conoco Inc. and from 1992 until 1994, as
Senior Vice President of E.I. duPont. Mr. Ogren is currently an Advisory
Director of Intrepid Energy (U.K.) Ltd. and a director of John Wood Group Plc.
He is a member of the Society of Petroleum Engineers and is a registered
professional engineer. Mr. Ogren has served as a Supervisory Director since
2000.
Joseph R. Perna joined our company as General Manager in 1985. In 1991, he
was promoted to Senior Vice President, with responsibility for certain
laboratory services operations and the Technology Products Division, a position
he held until his retirement on March 31, 1998. Mr. Perna has served as a
Supervisory Director since our initial public offering in 1995.
Jacobus Schouten serves on the board of directors of various European
companies, including International Mezzanine Capital B.V. Mr. Schouten has
served as a Supervisory Director since our initial public offering in 1995.
Alexander Vriesendorp has been a partner since 1996 of Shamrock Partners
B.V. which serves as the manager for the Vreedenlust venture capital funds. From
1998 until 2001, Mr. Vriesendorp served as Chief Executive Officer of RMI
Holland B.V. in The Netherlands. From 1991 until 1995, he served as Chief
Executive Officer of the Nienhuis Group in The Netherlands. Mr. Vriesendorp
serves on the supervisory boards of various European companies. He is also a
member of the board of the Leiden University Fund. Mr. Vriesendorp has served as
a Supervisory Director since 2000.
EXECUTIVE OFFICERS
Currently, our executive officers consist of David M. Demshur, Monty L.
Davis, Richard L. Bergmark and John D. Denson. Biographical information
regarding Messrs. Demshur and Bergmark is set forth above. The following
biographies describe the business experience of Messrs. Davis and Denson. Our
executive officers are not Managing Directors of our company for purposes of
Dutch law.
Monty L. Davis, who is 49 years of age, joined Western Atlas International
in 1977, holding various management positions including Atlas Wireline Division
Financial Controller for Europe, Africa and the Middle East from 1983 to 1987,
Core Laboratories Division Vice President of Finance from 1987 to 1991, and
Atlas Wireline Division Vice President of Finance and Administration from 1991
to 1993. In 1993, Mr. Davis left our company and joined Bovar Inc. of Calgary,
Canada, an environmental waste disposal company, as
3
Chief Financial Officer. From 1994 to 1995 he served as Chief Operating Officer
and from 1995 to 1998 he served as President and Chief Executive Officer. Mr.
Davis rejoined our company as Senior Vice President in 1998, and in 1999 was
promoted to Chief Operating Officer.
John D. Denson, who is 45 years of age, joined Western Atlas International
as Division Counsel in 1992, with responsibility for the Core Laboratories
division. Mr. Denson has served as our Vice President, General Counsel and
Secretary since 1994. Mr. Denson is a member of the State Bar of Texas.
SECURITY OWNERSHIP BY CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The table below sets forth certain information, as of March 25, 2003, with
respect to the common shares beneficially owned by:
- each person known to us to own beneficially five percent or more of our
outstanding common shares;
- each Supervisory Director;
- each of our executive officers; and
- all Supervisory Directors and executive officers as a group.
NUMBER OF PERCENTAGE OF
COMMON SHARES COMMON SHARES
NAME OF BENEFICIAL OWNER(1) BENEFICIALLY OWNED OUTSTANDING(2)
--------------------------- ------------------ --------------
Citigroup Inc.(3)..................................... 7,106,920 21.4%
Franklin Resource, Inc.(4)............................ 2,000,000 6.0%
David M. Demshur(5)**................................. 632,300 1.9%
Richard L. Bergmark(5)**.............................. 401,606 1.2%
Joseph R. Perna**..................................... 162,744 *
Monty L. Davis(5)**................................... 209,232 *
John D. Denson(5)**................................... 164,916 *
D. John Ogren**....................................... 51,000 *
Rene R. Joyce**....................................... 41,000 *
Jacobus Schouten**.................................... 30,000 *
Alexander Vriesendorp**............................... 21,000 *
All Supervisory Directors and executive officers as a
group**............................................. 1,713,798 5.0%
---------------
* Represents less than 1%.
** Includes the following common shares which may be acquired within 60 days
through the exercise of stock options: Mr. Demshur, 337,500; Mr. Bergmark,
239,750; Mr. Perna, 50,000; Mr. Davis, 176,250; Mr. Denson, 114,500; Mr.
Ogren, 21,000; Mr. Joyce, 21,000; Mr. Schouten, 30,000; Mr. Vriesendorp,
21,000; Total 1,011,000.
(1) Unless otherwise indicated, each person has sole voting power and investment
power with respect to the common shares listed.
(2) Based on 33,275,910 common shares issued and outstanding as of March 25,
2003.
(3) As reported on the Schedule 13G/A dated January 9, 2003, the common shares
reported by Citigroup Inc. include 7,010,656 common shares reported by
Salomon Smith Barney Holdings Inc., a wholly owned subsidiary of Citigroup
Inc. The common shares reported by Salomon Smith Barney Holdings include
5,327,156 common shares reported by Salomon Brothers Holding Company Inc.
and 1,683,500 common shares reported by Smith Barney Fund Management LLC,
both of which are wholly owned subsidiaries of Salomon Smith Barney
Holdings. The common shares reported by Salomon Smith Barney Holding Company
include 5,327,156 common shares reported by Salomon Smith Barney Inc., a
wholly owned subsidiary of Salomon Smith Barney Holding Company. The common
shares reported by each of these five entities include shares for which such
reporting person disclaims beneficial ownership. The business
4
address of Salomon Smith Barney, Salomon Smith Barney Holding Company and
Salomon Smith Barney Holdings is 388 Greenwich Street, New York, NY 10013,
the business address of Smith Barney Fund Management is 333 West 34th
Street, New York, NY 10001 and the business address of Citigroup Inc. is 399
Park Avenue, New York, NY 10043.
(4) As reported on the Schedule 13G/A dated January 30, 2003, the common shares
reported by Franklin Resource, Inc. are beneficially owned by one or more
open or closed-end investment companies or other managed accounts which are
advised by direct or indirect investment advisory subsidiaries of Franklin
Resource. Such advisory contracts grant to the advisory subsidiaries all
investment and/or voting power over the common shares. Charles B. Johnson
and Rupert H. Johnson, Jr. each own in excess of 10% of the outstanding
common stock of Franklin Resource and are the principal shareholders of
Franklin Resource. Franklin Resource and Messrs. Johnson and Johnson may be
deemed to be, for purposes of Rule 13d-3 under the Securities Exchange Act
of 1934, as amended, the beneficial owner of securities held by persons and
entities advised by Franklin Resource subsidiaries. Franklin Resource,
Messrs. Johnson and Johnson, and each of the advisory subsidiaries disclaim
economic interest or beneficial ownership in any of the common shares. The
business address of Franklin Resource is One Franklin Parkway, San Mateo, CA
94403.
(5) The common share ownership figures for Messrs. Demshur, Bergmark, Davis, and
Denson include 47,394, 49,259, 16,492 and 19,708 restricted shares,
respectively, awarded pursuant to the Executive Restricted Share Matching
Program described below under "Executive Compensation Program -- Executive
Restricted Share Matching Program."
DIRECTOR COMPENSATION
Each Supervisory Director who is not our full-time employee is paid:
- an annual retainer of $27,000, payable semiannually in arrears;
- $1,250 per meeting of the Supervisory Board at which the individual is
present in person;
- $1,250 per meeting for each committee meeting at which the individual is
present in person;
- $1,500 per meeting for each committee meeting at which the individual
serves as chairperson; and
- reimbursement for all out-of-pocket expenses incurred in attending any
Supervisory Board or committee meeting.
Supervisory Directors who are our full-time employees receive no
compensation for serving as Supervisory Directors.
Our 1995 Nonemployee Director Stock Option Plan, as amended, which we refer
to as the "Nonemployee Director Plan," provides for the issuance of up to
700,000 of our common shares to eligible Supervisory Directors. Under the
Nonemployee Director Plan, each eligible director is generally granted an option
to acquire 1,000 common shares on the date such individual first becomes an
eligible director. In addition, an option to acquire 10,000 common shares will
be granted to each nonemployee Supervisory Director (20,000 common shares if
such nonemployee Supervisory Director is the Chairman) each year generally on
the first date in the calendar year set by the Supervisory Board for the
issuance of stock options to more than ten employees under our 1995 Long-Term
Incentive Plan, as amended, which we refer to as the "Incentive Plan." In 2001,
the Nonemployee Director Plan was amended to provide that the stock option
grants with respect to the year 2002 would be granted on September 26, 2001.
Supervisory Directors who are also our employees receive no grants under the
Nonemployee Director Plan. Options granted will be exercisable for a period of
up to ten years and will vest one year following the date of grant. The exercise
price of options granted under the Nonemployee Director Plan will be equal to
the market price of our common shares on the date of grant.
5
EXECUTIVE COMPENSATION
The following table summarizes, with respect to our Chief Executive Officer
and each of our other executive officers, information relating to the
compensation earned for services rendered in all capacities during fiscal years
2000 through 2002.
LONG TERM COMPENSATION
-----------------------
RESTRICTED SECURITIES
ANNUAL COMPENSATION(1) SHARE UNDERLYING ALL OTHER
FISCAL ----------------------- AWARDS OPTIONS COMPENSATION
NAME AND PRINCIPAL POSITION YEAR SALARY BONUS (2)(3) (NUMBER) (4)
--------------------------- ------ ---------- ---------- ---------- ---------- ------------
David M. Demshur............. 2002 $447,923 -- $1,229,298 -- $24,067
President and Chief
Executive 2001 420,000 -- -- 250,000 20,432
Officer 2000 408,000 $200,000 -- 50,000 19,004
Richard L. Bergmark.......... 2002 $270,805 -- $ 964,848 -- $24,471
Executive Vice President, 2001 236,250 -- -- 100,000 20,322
Chief Financial Officer 2000 229,500 $ 75,000 -- 30,000 18,052
and Treasurer
Monty L. Davis............... 2002 $260,319 -- $ 515,940 -- $25,863
Chief Operating Officer and 2001 231,000 -- -- 150,000 21,982
Senior Vice President 2000 224,400 $ 75,000 -- 60,000 20,340
John D. Denson............... 2002 $214,160 -- $ 415,000 -- $25,673
Vice President, General 2001 199,500 -- -- 80,000 21,926
Counsel and Secretary 2000 193,800 $ 60,000 -- 30,000 20,199
---------------
(1) During the years ending December 31, 2000, 2001 and 2002, perquisites for
each individual named in the table above aggregated less than 10% of the
total annual salary and bonus reported for such individual. Accordingly, no
such amounts are included in the table.
(2) As described below under "Executive Compensation Program -- Executive
Restricted Share Matching Program," on June 1, 2002, Messrs. Demshur,
Bergmark, Davis and Denson were awarded 47,394, 49,259, 16,492 and 19,708
restricted shares, respectively, pursuant to an Executive Share Matching
Restricted Share Agreement. Pursuant to these agreements, the executives
were awarded a number of restricted shares equal to the number of common
shares the executives were deemed to have purchased in open market
transactions (including common shares acquired pursuant to the Core
Laboratories Profit Sharing and Retirement Plan (which we refer to as the
"401(k) Plan") or the Core Laboratories Deferred Compensation Plan). The
restricted shares will generally vest three years from the date of grant
assuming continued employment, continued ownership of the underlying common
shares upon which the grant was based and certain other conditions.
Dividends, if declared, will be paid on the restricted shares prior to
vesting. The value of the restricted share matching awards included in the
table above were $649,298, $674,848, $225,940 and $270,000 for Messrs.
Demshur, Bergmark, Davis and Denson, respectively, and were calculated, as
required by SEC rules, by multiplying the number of restricted shares
awarded by the closing price of our unrestricted common shares on the NYSE
as of June 3, 2002, the first trading day following the award date. As of
December 31, 2002, the value of these restricted share awards, calculated in
the same manner, would have been $537,922, $559,090, $187,184 and $223,686
for Messrs. Demshur, Bergmark, Davis and Denson, respectively.
(3) Effective as of January 1, 2002, Messrs. Demshur, Bergmark, Davis and Denson
were awarded 40,000, 20,000, 20,000 and 10,000 performance restricted
shares, respectively, which represent the right to receive our common shares
in the future. None of these awards will vest unless our common shares
perform better than the common stock of 50% of the companies comprising the
Oil Service Sector Index (OSX) during the three-year period that began
January 1, 2002. If our common shares perform better than 75% of the
companies comprising this index during such period, then all of the
performance restricted shares will vest. If our common shares perform better
than between 50% and 75% of the companies comprising the index, then an
interpolated percentage of between 20% and 100% of the performance
restricted shares will vest at the end of the three-year period. Dividends,
if declared, will not
6
be paid on the restricted shares prior to vesting. The value of the
performance restricted share awards included in the table above were
$580,000, $290,000, $290,000 and $145,000 for Messrs. Demshur, Bergmark,
Davis and Denson, respectively, and were calculated, as required by SEC
rules, by multiplying the number of performance restricted shares awarded by
the closing price of our unrestricted common shares on the NYSE as of
January 2, 2002, the first trading day following the award date. As of
December 31, 2002, the value of these restricted share awards, calculated in
the same manner, would have been $454,000, $227,000, $227,000 and $113,500
for Messrs. Demshur, Bergmark, Davis and Denson, respectively.
(4) Consists of matching contributions and contributions by our company through
our retirement plans, amounts paid under certain insurance plans and a
transportation allowance.
2002 OPTION EXERCISES AND YEAR-END VALUE TABLE
The following table sets forth for our executive officers information
regarding options held by them at December 31, 2002.
SECURITIES VALUE OF SECURITIES
UNDERLYING UNEXERCISED UNDERLYING UNEXERCISED
SHARES OPTIONS HELD OPTIONS HELD
ACQUIRED AT DECEMBER 31, 2002 AT DECEMBER 31, 2002(1)
ON EXERCISE VALUE --------------------------- ---------------------------
NAME OF OPTION REALIZED EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
---- ----------- -------- ----------- ------------- ----------- -------------
David M. Demshur........ -- -- 292,500 207,500 $368,500 $101,500
Richard L. Bergmark..... -- -- 221,000 85,000 408,006 41,869
Monty L. Davis.......... -- -- 152,500 127,500 34,256 62,169
John D. Denson.......... -- -- 103,250 63,750 148,563 32,988
---------------
(1) Computed based on the difference between aggregate fair market value and
aggregate exercise price. The fair market value of our common shares on
December 31, 2002 was based on the average of the high and low sales prices
on the NYSE on such date.
EQUITY COMPENSATION PLAN INFORMATION
We have two main stock option plans, our Incentive Plan and our Nonemployee
Director Plan, both of which have been approved by our shareholders. We also
have assumed outstanding stock options in connection with some of our
acquisitions that did not require shareholder approval. The options that we have
assumed in connection with acquisitions have not been approved by our
shareholders. The table below provides information regarding our equity
compensation plans.
NUMBER OF COMMON NUMBER OF COMMON
SHARES TO BE ISSUED WEIGHTED AVERAGE SHARES REMAINING
UPON EXERCISE OF EXERCISE PRICE OF AVAILABLE FOR FUTURE
OUTSTANDING OPTIONS, OUTSTANDING OPTIONS, ISSUANCE UNDER EQUITY
WARRANTS AND RIGHTS WARRANTS AND RIGHTS COMPENSATION PLANS
-------------------- -------------------- ---------------------
Equity compensation plans approved
by our shareholders............. 3,892,669 $12.92 1,289,906
Equity compensation plans not
approved by our shareholders.... 211,843 5.87 --
--------- ------ ---------
Total............................. 4,104,512 $12.37 1,289,906
========= ====== =========
EMPLOYMENT AND CHANGE OF CONTROL AGREEMENTS
David M. Demshur Employment Agreement. Mr. Demshur serves as our President
and Chief Executive Officer pursuant to an employment agreement that is
currently set to expire in 2005. Unless either party gives notice to terminate
the agreement, the agreement will automatically renew each year on the
anniversary of the effective date for a successive three-year term. Mr.
Demshur's employment agreement entitles him to a base salary of $420,000,
subject to increase at the discretion of the Compensation Committee, and the
opportunity
7
to earn a yearly bonus of up to 150% of his then current annual base salary
dependent upon his reaching certain performance objectives established by the
Compensation Committee and described below under "Executive Compensation
Program -- Annual Incentive Compensation." The employment agreement provides
that Mr. Demshur is entitled to participate in all of our company's benefit
plans and programs and also contains non-compete provisions in the event Mr.
Demshur's employment with our company is terminated.
Mr. Demshur's employment agreement also includes provisions governing the
payment of severance benefits if his employment is terminated by him for any
reason or by the company for any reason other than upon his death or disability,
for "cause" or upon a material breach of a material provision of his employment
agreement. Any severance benefits shall be made as follows:
- the payment of a lump sum amount equal to the sum of:
- 200% of his base salary as in effect immediately prior to the
termination; and
- two times 45% of the maximum annual incentive bonus he could have earned
pursuant to his employment contract;
- the provision of a benefits package for Mr. Demshur and his dependants
which includes medical, hospital, dental, disability and life insurance
plans and coverage at least as favorable as those provided immediately
prior to the termination for as long as Mr. Demshur and his dependents
are living;
- the payment of a lump sum amount equal to the non-vested employer
contributions allocated to his account under our 401(k) Plan that are
forfeited as a result of the termination;
- the full and immediate vesting of all of his outstanding stock options
which options shall remain exercisable for a period of three months
following such termination; and
- the provision of outplacement services at a cost not to exceed 100% of
the his annual base salary as in effect immediately prior to the
termination.
If Mr. Demshur's employment is terminated as a result of his death or
disability, Mr. Demshur (if living) and his dependents will be entitled to the
benefits described under the second and forth bullet points above. If Mr.
Demshur's employment is terminated for any reason within three years following a
"change in control," as defined in his employment agreement, he will be entitled
to the same benefits described above except that (A) under certain circumstances
the options vested pursuant to the fourth bullet point above will generally
remain exercisable for a period of one year and (B) the lump sum payment
described in the first bullet point above shall be equal to the sum of:
- 300% of his base salary as in effect immediately prior to the change in
control; and
- three times the higher of (A) 45% of the maximum annual incentive bonus
he could have earned pursuant to his employment contract or (B) the
highest annual bonus he received in the three years prior to the change
of control.
Additionally, if any of the payments or benefits described above would be
subject to the excise tax imposed by Section 4999 of the Internal Revenue Code
of 1986, as amended, then Mr. Demshur will be entitled to receive a gross-up
payment equal to the amount of excise tax imposed plus all taxes imposed on the
gross-up payment.
Richard L. Bergmark Employment Agreement. Mr. Bergmark serves as our
Treasurer and Chief Financial Officer pursuant to an employment agreement that
is currently set to expire in 2005. Mr. Bergmark's employment agreement entitles
him to a base salary of $236,250, subject to increase at the discretion of the
Compensation Committee, and the opportunity to earn a yearly bonus of up to 100%
of his then current annual base salary dependent upon his reaching certain
performance objectives established by the Compensation Committee. The other
terms of Mr. Bergmark's amended and revised employment agreement are
substantially identical to those contained in Mr. Demshur's employment agreement
described above.
Monty L. Davis Employment Agreement. Mr. Davis serves as our Chief
Operating Officer pursuant to an employment agreement that is currently set to
expire in 2005. Mr. Davis' employment agreement entitles
8
him to a base salary of $231,000, subject to increase at the discretion of the
Compensation Committee, and the opportunity to earn a yearly bonus of up to 100%
of his then current annual base salary dependent upon his reaching certain
performance objectives established by the Compensation Committee. The other
terms of Mr. Davis' amended and revised employment agreement are substantially
identical to those contained in Mr. Demshur's employment agreement described
above.
John D. Denson Employment Agreement. Mr. Denson serves as our General
Counsel, Vice President and Secretary pursuant to an employment agreement that
is currently set to expire in 2005. Mr. Denson's employment agreement entitles
him to a base salary of $199,500, subject to increase at the discretion of the
Compensation Committee, and the opportunity to earn a yearly bonus of up to 75%
of his then current annual base salary dependent upon his reaching certain
performance objectives established by the Compensation Committee. The other
terms of Mr. Denson's amended and revised employment agreement are substantially
identical to those contained in Mr. Demshur's employment agreement described
above.
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Exchange Act requires the Supervisory Directors,
executive officers and persons who own more than ten percent of our common
shares to file initial reports of ownership and reports of changes in ownership
(Forms 3, 4 and 5) of our common shares with the SEC and the NYSE. Supervisory
Directors, executive officers and greater than ten percent shareholders are
required by SEC regulations to furnish us with copies of all such forms that
they file.
To our knowledge, based upon our review of the Section 16(a) filings that
have been received by us, we believe that during the fiscal year ending December
31, 2002, our Supervisory Directors, executive officers and ten percent
shareholders complied with the applicable Section 16(a) filing requirements
except that Messrs. Demshur, Bergmark, Davis and Denson filed amended Form 5's
with respect to the year ended December 31, 2002 to include the performance
restricted shares disclosed above.
COMMITTEES OF THE SUPERVISORY BOARD
The Supervisory Board has three standing committees, the identities,
memberships and functions of which are described below:
Audit Committee. The current members of the Audit Committee of our
Supervisory Board are Messrs. Perna (Chairman), Joyce and Ogren. The Audit
Committee's principal functions include making recommendations concerning the
engagement of the independent accountants, reviewing with the independent
accountants the plan and results of the auditing engagement, approving
professional services provided by the independent accountants and reviewing the
adequacy of our internal accounting controls. Each member of the Audit Committee
is independent as defined by the corporate governance standards of the New York
Stock Exchange. The Supervisory Board has developed a written charter for our
audit committee which was filed as an appendix to our proxy statement in 2001.
Compensation Committee. The current members of the Compensation Committee
of our Supervisory Board are Messrs. Ogren (Chairman) and Perna. The
Compensation Committee's principal functions include a general review of our
compensation and benefit plans to ensure that they are properly designed to meet
corporate objectives. The Compensation Committee reviews and approves the Chief
Executive Officer's recommendations on the compensation of our senior executive
officers, granting of awards under our benefit plans and adopting and changing
major compensation policies and practices. In addition to establishing the
compensation for the Chief Executive Officer, the Compensation Committee reports
its recommendations to the whole Supervisory Board for approval. On February 28,
2003, our Supervisory Board established an Options Subcommittee of the
Compensation Committee consisting of Messrs. Ogren (Chairman) and Joyce. The
Options Subcommittee's principal function is to review and approve awards made
pursuant to our Incentive Plan.
Nominating and Governance Committee. On November 12, 2002, the Supervisory
Board established a Nominating and Governance Committee of the Supervisory
Board. The current members of the Nominating
9
and Governance Committee are Messrs. Joyce (Chairman), Ogren, Schouten and
Vriesendorp. The Nominating and Governance Committee's principal functions
include recommending candidates to the full board for election or appointment as
Supervisory Director and advising about, and recommending to the Supervisory
Board, an appropriate set of corporate governance practices. Each member of the
Nominating and Governance Committee is independent as defined by the corporate
governance standards of the New York Stock Exchange.
The Supervisory Board held five meetings in 2002, the Audit Committee held
eight meetings in 2002, the Compensation Committee held one meeting in 2002 and
the Nominating and Governance Committee held no meetings in 2002. Each
Supervisory Director attended at least 75% of the meetings of the Supervisory
Board and of all committees on which he serves.
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
During 2002, no executive officer served as:
- a member of the compensation committee (or other board committee
performing equivalent functions or, in the absence of any such committee,
the entire board of directors) of another entity, one of whose executive
officers served as one of our Supervisory Directors; or
- a director of another entity, one of whose executive officers served on
our Supervisory Board or the board of directors of one of our
subsidiaries.
Joseph R. Perna, a member of our Compensation Committee, is a former
officer of our company.
REPORT OF THE COMPENSATION COMMITTEE ON EXECUTIVE COMPENSATION
The Compensation Committee's responsibilities are:
- to oversee the development of the compensation program for our officers
and managerial employees;
- to administer the incentive and stock option plans, including approval of
grants and awards under these plans (currently the Options Subcommittee
of the Compensation Committee handles these responsibilities); and
- to establish the compensation program for our Chief Executive Officer and
our other executive officers.
Our Compensation Committee is comprised of Joseph R. Perna and D. John Ogren,
neither of whom are our employees.
Executive Compensation Philosophy. The objective of the compensation
program for officers and managers is to create strong financial incentives for
corporate and division officers and managers to increase profits, revenues and
operating efficiency, which we expect to lead to an increase in shareholder
value. The following objectives guide the Compensation Committee in its
deliberations:
- provide a competitive compensation program that enables us to attract and
retain key executives and Supervisory Board members;
- ensure a strong relationship between our performance results and those of
our divisions and the total compensation received by an individual;
- balance our annual and longer term performance objectives;
- encourage executives to acquire and retain meaningful levels of common
shares; and
- work closely with our Chief Executive Officer to ensure that the
compensation program supports our management style, objectives and
culture.
In addition to normal employee benefits, the executive total compensation
program includes base salary, annual cash incentive compensation and longer term
stock-based grants and awards.
10
Market Comparisons. Primary market comparisons for executive compensation
are made to other oilfield service companies, adjusted for size and job
responsibilities. The companies used for market comparisons in the development
of the compensation program are broader than those used in the performance graph
presented elsewhere in this proxy statement and are used because they are more
representative of the market in which we compete for executive talent. Data
sources include peer company proxy disclosures, oilfield industry surveys,
national survey databases and general trend data provided by consultants.
Variable Incentives. Variable incentives, both annual and longer term, are
major components of the program and are used to link pay with performance
results appropriate to each executive officer or manager. Variable incentive
awards and performance objectives are calibrated such that total compensation
will approximate the market 50th percentile when our performance plans are
achieved and exceed the 50th percentile when our performance plans are exceeded.
Internal Revenue Code Section 162(m). Internal Revenue Code Section 162(m)
imposes a $1,000,000 limit, with certain exceptions, on the deductibility of
compensation paid to each of our five highest paid executive officers. In
particular, compensation that is determined to be "performance based" is exempt
from this limitation. To be "performance based," incentive payments must use
predetermined objective standards, limit the use of discretion in making awards
and be certified by a committee of our Supervisory Board made up of "outside
directors." To date, we have not lost any tax deductions related to the
limitations of Section 162(m). The Compensation Committee will continue to
monitor these issues and will take appropriate action if it is warranted in the
future.
EXECUTIVE COMPENSATION PROGRAM
The following is a discussion of each of the principal components of the
executive total compensation program.
Base Salary. The base salary program targets the median of the primary
comparison group for corporate and divisional officers and managers. Each
executive is reviewed individually on an annual basis. Salary adjustments are
based on the individual's experience and background, the individual's
performance during the prior year, the general movement of salaries in the
marketplace and our financial position. As a result of these factors, an
executive's base salary may be above or below the targeted median at any point
in time.
Annual Incentive Compensation. We administer an annual incentive plan for
our corporate and divisional officers and managers. The goal of the plan is to
reward participants in proportion to our performance as a whole, the performance
of the division for which they have direct responsibility and their individual
contributions to our success.
For 2002, corporate participants were measured on earnings before interest
and taxes, or "EBIT," and earnings per share, while division participants were
also measured on working capital management. In addition, a discretionary
component was included as part of the plan so that outstanding effort and
dedication could be recognized. The measures were weighted substantially
equally.
Supplemental Executive Retirement Plans. In 1998, we adopted the Core
Laboratories Supplemental Executive Retirement Plan, which we refer to as the
"Group SERP," for the benefit of certain key employees and outside directors.
The Group SERP was established to provide additional retirement income to the
participants and death benefits to the participants' designated beneficiaries as
a reward for the participants' contributions to our success and growth. The four
participants in the Group SERP are Richard L. Bergmark, David M. Demshur, Joseph
R. Perna and Stephen D. Weinroth. Mr. Weinroth served as Chairman of our
Supervisory Board until May 2001. Each participant is entitled to receive a
retirement benefit of $250,000 per year, which begins on the participant's
retirement date and is paid in annual installments until the participant's
death. If a participant dies on or after his retirement date and prior to
receiving 15 annual installments of his retirement benefit, then the
participant's designated beneficiary is entitled to receive $250,000 each year
until such payments have been made for an aggregate of 15 years to both the
participant and such designated beneficiary. If the participant dies before his
retirement date, the designated beneficiary of the deceased participant is
entitled to receive $225,000 each year for 15 years. Each participant's benefit
under the Group
11
SERP is fully vested and fully accrued. Additionally, the participant may make a
prior election to receive a lump sum payment upon a "change of control" of our
company equal to the discounted present value of the retirement benefits that
would have been paid upon the participant's retirement. Benefits under the Group
SERP may be forfeited only in the event of a participant's termination for
cause. We expect to begin making payments to Mr. Weinroth under the Group SERP
in 2003 when Mr. Weinroth turns 65.
In 1999, we adopted the Core Laboratories Supplemental Executive Retirement
Plans for Monty L. Davis and John D. Denson, which we refer to as the
"Individual SERPs." The Individual SERPs were established to provide additional
retirement income for Messrs. Davis and Denson and death benefits for their
designated beneficiaries as a reward for their respective contributions to our
success and growth. Each is entitled to receive a retirement benefit commencing
on his retirement date. The amount of the retirement benefit is determined using
a formula that takes into consideration the participant's compensation, years of
employment, and a five year vesting schedule, and is paid in annual installments
until the participant's death. Vesting in this retirement benefit is accelerated
upon a "change in control" of our company. If a participant dies on or after his
retirement date and prior to receiving 15 annual installments of his retirement
benefit, then the designated beneficiary of the deceased participant is entitled
to receive the payments the deceased participant would have received if the
participant's death had not occurred. Such payments will continue until payments
for an aggregate of 15 years have been made to both the participant and his
designated beneficiary. If a participant dies prior to his retirement date, the
designated beneficiary of the deceased participant is entitled to receive annual
payments for 15 years, and the amount of such payments is determined using a
formula similar to that described above. Additionally, the participant may make
a prior election to receive a lump sum payment upon a "change of control" of our
company equal to the discounted present value of the retirement benefits that
would have been paid upon the participant's retirement. Benefits under an
Individual SERP may be forfeited upon a participant's termination for cause.
We have purchased insurance coverage on the lives of Messrs. Bergmark,
Demshur, Perna, Davis and Denson to assist us in providing benefits under the
Group and Individual SERPs. We are the owner and beneficiary of the insurance
coverage and are obligated to pay the total premium of $319,500 and $82,191 each
year for the Group SERP and the Individual SERPs, respectively, until the
policies are paid up (which we anticipate will occur in 2005). Based on
actuarial calculations (including a 12% earnings rate assumption), we expect
that the death benefits paid to us under the insurance policies will be
sufficient to cover the costs of the Group and Individual SERPs' benefits and
the policy premium payments for these individuals. However, to the extent the
death benefits under the policies are insufficient to cover those costs, we are
obligated to pay the remainder out of our other general assets to absorb any
shortfall. In the event of a "change of control," we may fully fund the amount
of the retirement benefits and death benefits of all six participants in the
Group and Individual SERPs and their designated beneficiaries.
Deferred Compensation Plan. Core Laboratories LP, one of our principal
subsidiaries, has adopted a deferred compensation plan that allows certain
officers, including all of our executive officers, to defer a portion of their
salary and bonus, as well as the amount of any reductions in their deferrals
under the 401(k) Plan, due to certain limitations imposed by the Internal
Revenue Code of 1986, as amended. The plan also provides for employer
contributions to be made on behalf of participants equal in amount to certain
forfeitures of, and/or reductions in, employer contributions that participants
could have received under the 401(k) Plan in the absence of certain limitations
imposed by the Internal Revenue Code. These employer contributions vest
gradually over a period of five years. Discretionary employer contributions may
also be made on behalf of participants in the plan and are subject to
discretionary vesting schedules determined at the time of such contributions.
Vesting in all employer contributions is accelerated upon the death of the
participant or a "change in control." Employer contributions under the plan are
forfeited upon a participant's termination of employment to the extent they are
not vested at that time.
Stock Based Compensation. Stock ownership by corporate and divisional
management is encouraged through the use of the Incentive Plan which provides
for the award of our common shares and options to buy our common shares. The
Compensation Committee and management believe that widespread common share
ownership by key employees is an important means of encouraging superior
performance and employee retention. Common share option grants are considered
annually based on competitive multiples of base salary.
12
Senior executives typically have a higher multiple and, as a result, have a
greater portion of their total compensation linked to our long-term success. In
determining the appropriate grant multiples, we target the market median among
publicly-held oilfield service companies of similar size. In 2002, our executive
officers did not receive stock option grants.
In 2002, we made performance restricted share awards to members of our
corporate and divisional management, including our executive officers. These
performance restricted share awards represent the right to receive our common
shares in the future. Assuming the employee's continued employment (or death or
disability while employed), these awards will vest on December 31, 2004 based on
the performance of our common shares as compared to that of the common stock of
the companies comprising the Oil Service Sector Index (OSX). None of these
awards will vest unless our common shares perform better than the common stock
of 50% of the companies comprising this index during the three-year period that
began on January 1, 2002. If our common shares perform better than 75% of the
companies comprising the index during such period, then all of the performance
restricted shares will vest. If our common shares perform better than between
50% and 75% of the companies comprising the index, then an interpolated
percentage of between 20% and 100% of the performance restricted shares will
vest at the end of the three-year period. Upon a "change in control" of our
company, all of the performance restricted shares will vest.
Executive Restricted Share Matching Program. In 2002, we implemented an
Executive Restricted Share Matching Program to encourage personal investment in
our common shares by our executive officers. Under the program, Messrs. Demshur,
Bergmark, Davis and Denson were granted a number of restricted shares equal to
the number of common shares such executive officer had purchased in open market
transactions or held in his deferred compensation, 401(k) or other retirement
account as of June 1, 2002. The number of shares that an executive officer was
eligible to have matched was capped at 50,000 shares. Pursuant to the program,
Messrs. Demshur, Bergmark, Davis and Denson were awarded 47,394, 49,259, 16,492
and 19,708 restricted shares, respectively. The shares will vest three years
from the date of grant assuming the executive's continued employment with our
company and continued ownership of the underlying common shares upon which the
grant was based. These awards will also vest immediately upon the death or
disability of the participant, his involuntary termination without cause or a
"change in control" of our company.
The agreements governing the awards also provide that each executive
officer is entitled to receive an additional restricted share award upon the
vesting of the initial restricted shares in order to reimburse the executive for
the amount of tax payable by the executive upon the vesting of the initial
restricted shares (including any tax due as a result of the tax gross-up
itself). If the initial restricted shares vest as a result of any of the events
listed in the last sentence of the preceding paragraph, the executive will be
granted a lump sum cash payment equal to the amount of tax due (including any
tax due as a result of the tax gross-up itself) rather than a grant of
restricted shares. The additional restricted shares will vest two years from the
date of the grant assuming the executive's continued employment with our
company, continued ownership of the common shares upon which the initial grant
was based and continued ownership of the vested initial restricted shares (less
a number of restricted shares equal in value to the amount of tax the executive
was required to pay upon the vesting of the initial restricted shares). These
additional awards will also vest immediately upon the death or disability of the
participant, his involuntary termination without cause or a "change in control"
of our company.
13
COMPENSATION OF THE CHIEF EXECUTIVE OFFICER
Our Chief Executive Officer, David M. Demshur, participates in the
executive compensation program described above. In establishing the base salary
for Mr. Demshur, our Compensation Committee assessed the pay levels for chief
executive officers in similar companies in the oilfield service industry and our
profit performance. In 2002, Mr. Demshur's base salary was $447,923. He received
no stock options in 2002 and did not receive an annual incentive award for 2002.
Mr. Demshur received an award of 40,000 performance restricted shares in 2002
and a grant of 47,394 restricted shares pursuant to the Executive Restricted
Share Matching Program described above.
Submitted by the Compensation Committee of the Board of Supervisory
Directors.
COMPENSATION COMMITTEE
D. John Ogren (Chairman)
Joseph R. Perna
REPORT OF THE AUDIT COMMITTEE
The Audit Committee has reviewed and discussed with management Core
Laboratories' audited financial statements as of and for the year ended December
31, 2002.
The Audit Committee has discussed with the independent auditors the matters
required to be discussed by Statements on Auditing Standards No. 61,
Communication with Audit Committees, as amended, by the Auditing Standards Board
of the American Institute of Certified Public Accountants.
The Audit Committee has received and reviewed the written disclosures and
the letter from the independent auditors required by Independence Standard No.
1, Independence Discussions with Audit Committees, as amended, by the
Independence Standards Board, and has discussed with the auditors the auditors'
independence.
Based on the reviews and discussions referred to above, the Audit Committee
recommends to the Supervisory Board that the financial statements referred to
above be included in the Core Laboratories' Annual Report on Form 10-K for the
year ended December 31, 2002.
Submitted by the Audit Committee of the Board of Supervisory Directors.
AUDIT COMMITTEE
Joseph R. Perna (Chairman)
Rene R. Joyce
P. John Ogren
FISCAL 2002 AUDIT FEE SUMMARY
Set forth below is a summary of the total fees paid to our independent
public accountants, PricewaterhouseCoopers LLP, for fiscal 2002. These fees
consisted of:
Audit Fees.................................................. $1,438,485
Financial Information Systems Design and Implementation
Fees...................................................... --
All Other Fees.............................................. 86,376
----------
Total..................................................... $1,524,861
==========
In determining the independence of PricewaterhouseCoopers LLP for purposes
of its 2002 audit, the Audit Committee considered whether the rendering of
non-audit services was compatible with maintaining
14
PricewaterhouseCoopers LLP's independence and concluded that
PricewaterhouseCoopers LLP's independence was not compromised by the provision
of such services.
SHAREHOLDER RETURN PERFORMANCE PRESENTATION
The following performance graph compares the performance of our common
shares to the Standard & Poor's 500 Index and the Standard & Poor's Oil Well
Equipment and Services Index (which has been selected as our peer group) for the
period beginning January 1, 1998 and ending December 31, 2002. The graph assumes
that the value of the investment in our common shares and each index was $100 at
January 1, 1998 and that all dividends were reinvested. Our common shares began
trading on the Nasdaq Stock Market in September 1995 and in July 1998 ceased
trading on the Nasdaq Stock Market and began trading on the New York Stock
Exchange.
COMPARISON OF QUARTERLY CUMULATIVE RETURNS
AMONG CORE LABORATORIES N.V.,
PEER GROUP INDEX AND THE S&P 500 INDEX
(PERFORMANCE GRAPH)
------------------------------------------------------------------------------------------------------------------------------------
1/1/98 3/31/98 6/30/98 9/30/98 12/31/98 3/31/99 6/30/99 9/30/99 12/31/99 3/31/00 6/30/00
------------------------------------------------------------------------------------------------------------------------------------
Core Laboratories
N.V. 100.00 134.95 123.67 103.44 114.30 106.14 85.85 120.23 126.54 171.85 171.85
Peer Group 100.00 97.06 87.91 57.05 50.98 82.23 95.89 89.65 85.55 111.60 114.86
S&P 500 Index 100.00 108.13 112.08 99.84 121.33 131.94 138.65 132.10 146.64 148.64 145.70
---------------------------------------------------------------------------------------------------------------------------
9/30/00 12/31/00 3/31/01 6/30/01 9/30/01 12/31/01 3/31/02 6/30/02 9/30/02 12/31/02
---------------------------------------------------------------------------------------------------------------------------
Core Laboratories
N.V. 156.37 167.56 136.29 136.18 104.77 113.79 119.06 100.50 78.45 99.59
Peer Group 124.12 117.30 98.38 91.45 71.85 80.59 89.27 72.27 56.98 70.45
S&P 500 Index 144.46 136.37 124.25 129.77 114.79 126.32 125.15 111.42 93.78 101.70
15
The foregoing stock price performance comparisons shall not be deemed
incorporated by reference by any general statement incorporating by reference
this proxy statement into any filing under the Securities Act of 1933, as
amended, or under the Exchange Act, except to the extent that we specifically
incorporate this graph by reference, and shall not otherwise be deemed filed
under such acts.
There can be no assurance that our common share performance will continue
into the future with the same or similar trends depicted in the graph above. We
will not make or endorse any predictions as to future performance of our common
shares.
CHANGE IN INDEPENDENT PUBLIC ACCOUNTANTS
On April 10, 2002, our Supervisory Board, upon the recommendation of our
Audit Committee, made a determination to dismiss Arthur Andersen LLP as our
independent public accountants and selected PricewaterhouseCoopers LLP to serve
as our independent public accountants for the fiscal year ending December 31,
2002.
Arthur Andersen LLP's reports on our consolidated financial statements for
each of the years ended December 31, 2001 and 2000 did not contain an adverse
opinion or disclaimer of opinion, nor were they qualified or modified as to the
uncertainty, audit scope or accounting principles. Arthur Andersen LLP's reports
on our consolidated financial statements for the year ended December 31, 2001
were filed with our Annual Report on Form 10-K for the year ended December 31,
2001.
During the years ended December 31, 2001 and 2000 and through the end of
the period during which they served as our independent public accountants, there
were no disagreements with Arthur Andersen LLP on any matter of accounting
principles or practices, financial statement disclosure, or auditing scope or
procedure which, if not resolved to Arthur Andersen LLP's satisfaction, would
have caused them to make reference to the subject matter in connection with
their report on our consolidated financial statements for such years. There were
no reportable events as listed in Item 304(a)(1)(v) of Regulation S-K.
During the years ended December 31, 2001 and 2000 and through the date of
their engagement as our independent public accountants in April 2002, we did not
consult PricewaterhouseCoopers LLP with respect to the application of accounting
principles to a specified transaction, either completed or proposed, or the type
of audit opinion that might be rendered in our consolidated financial
statements, or any other matters or reportable events as set forth in Items
304(a)(2)(i) and (ii) of Regulation S-K.
ITEM 2
APPROVAL OF ANNUAL ACCOUNTS
At the annual meeting, our shareholders will be asked to approve our Dutch
Statutory Annual Accounts for the fiscal year ending December 31, 2002, as
required under Dutch law and our articles of association. In accordance with
Article 408 of the Dutch Civil Code, the Annual Accounts are our annual accounts
and our participation and do not represent the consolidated accounts of our
company and subsidiaries as presented in our Consolidated Financial Statements
contained in our Annual Report for the year ending December 31, 2002.
The affirmative vote of the majority of the votes cast at the annual
meeting is required to adopt the Annual Accounts.
THE SUPERVISORY BOARD RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE ADOPTION
OF THE ANNUAL ACCOUNTS, AND PROXIES EXECUTED AND RETURNED WILL BE SO VOTED
UNLESS CONTRARY INSTRUCTIONS ARE INDICATED THEREON.
16
ITEM 3
EXTENSION OF AUTHORITY OF MANAGEMENT BOARD UNTIL
NOVEMBER 22, 2004 TO REPURCHASE SHARES
Under Dutch law, our articles of association and subject to certain Dutch
statutory provisions, we may repurchase up to 10% of our outstanding share
capital in open market purchases at any price that does not exceed $200.00 per
share or its equivalent in other currencies. This $200.00 limit is an arbitrary
number used to satisfy Dutch statutory provisions and our articles of
association and is not reflective of the price that would actually be paid in
any such repurchase unless the market price of our common shares approximated
such amount on the date of repurchase. Any such purchases are subject to the
approval of the Supervisory Board and the authorization of our shareholders at
the annual meeting, which authorization must be renewed every 18 months. In
connection with our initial public offering in September 1995, our shareholders
authorized our Management Board to make such repurchases for a period of 18
months. At each annual meeting subsequent to 1995, our shareholders have
extended the period such that the current period is set to expire on November
29, 2003. In 2002, we repurchased approximately 860,400 of our common shares for
an aggregate purchase price of approximately $9.0 million. In 2003 through March
31, we have repurchased approximately 790,800 of our common shares for an
aggregate purchase price of approximately $8.9 million. We believe that it is in
the best interest of our company and shareholders to have the flexibility to
repurchase shares in the future if the Supervisory Board deems it advisable to
do so. THIS AUTHORITY IS SIMILAR TO THAT GENERALLY AFFORDED UNDER STATE LAW TO
PUBLIC COMPANIES DOMICILED IN THE UNITED STATES.
At the annual meeting, our shareholders will be asked to approve a further
extension of this authority for an additional 18-month period from the date of
the annual meeting until November 22, 2004.
The affirmative vote of the majority of the votes cast at the annual
meeting is required to extend the authorization of the management board to
repurchase up to 10% of our outstanding share capital for an additional 18-month
period from the date of the annual meeting.
THE SUPERVISORY BOARD RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE EXTENSION
OF THE AUTHORITY OF THE MANAGEMENT BOARD TO REPURCHASE UP TO 10% OF OUR
OUTSTANDING SHARE CAPITAL UNTIL NOVEMBER 22, 2004 AT A PRICE NOT TO EXCEED
$200.00 PER SHARE, AND PROXIES EXECUTED AND RETURNED WILL BE SO VOTED UNLESS
CONTRARY INSTRUCTIONS ARE INDICATED THEREON.
ITEM 4
EXTENSION OF AUTHORITY OF SUPERVISORY BOARD
TO ISSUE SHARES OF CORE LABORATORIES N.V. UNTIL MAY 22, 2008
Under Dutch law and our articles of association, the Supervisory Board has
the power to issue shares of our share capital as long as the Supervisory Board
has been designated and authorized by the shareholders to do so at the annual
meeting. An authorization of the Supervisory Board to issue shares may be
effective for a period of up to five years and may be renewed on an annual
rolling basis. In connection with our initial public offering in September 1995,
our shareholders authorized the Supervisory Board to issue shares and/or rights
with respect to our shares for a five-year period. At each annual meeting
subsequent to 1995, our shareholders have extended the period such that the
current period is set to expire on May 29, 2007.
At the annual meeting, our shareholders will be asked to approve a further
extension of this authority for a five-year period from the date of the annual
meeting until May 22, 2008. THIS AUTHORITY TO ISSUE SHARES IS SIMILAR TO THAT
GENERALLY AFFORDED UNDER STATE LAW TO PUBLIC COMPANIES DOMICILED IN THE UNITED
STATES. Management believes that retaining the flexibility to issue shares for
acquisition, financing or other business purposes in a timely manner without
first obtaining specific shareholder approval is important to our continued
growth. Furthermore, our common shares are listed on the NYSE and, accordingly,
the issuance of additional shares will remain subject to the rules of the NYSE.
In particular, the NYSE requires shareholder approval for the issuance of shares
of common stock in excess of twenty percent of the shares outstanding except for
17
public offerings for cash or bona fide private offerings at a price greater than
both the book and market value of a company's common stock.
The affirmative vote of the majority of the votes cast at the annual
meeting is required to extend the authority of the Supervisory Board to issue
and/or to grant rights (including options to purchase) with respect to our
common and/or preference shares for a five-year period from the date of the
annual meeting.
THE SUPERVISORY BOARD RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE EXTENSION
OF THE AUTHORITY OF THE SUPERVISORY BOARD TO ISSUE AND/OR TO GRANT RIGHTS
(INCLUDING OPTIONS TO PURCHASE) WITH RESPECT TO OUR COMMON AND/OR PREFERENCE
SHARES UNTIL MAY 22, 2008, AND PROXIES EXECUTED AND RETURNED WILL BE SO VOTED
UNLESS CONTRARY INSTRUCTIONS ARE INDICATED THEREON.
ITEM 5
EXTENSION OF AUTHORITY OF SUPERVISORY BOARD
TO LIMIT OR ELIMINATE PREEMPTIVE RIGHTS UNTIL MAY 22, 2008
Holders of our common shares (other than our employees and employees of our
subsidiaries who are issued common shares pursuant to the exercise of options
granted under the Incentive Plan and the Nonemployee Director Plan) have a pro
rata preemptive right of subscription to any of our common shares issued for
cash unless such right is limited or eliminated by our Supervisory Board.
Holders of our common shares have no pro rata preemptive subscription right with
respect to any common shares issued for consideration other than cash. If
designated and authorized by our shareholders at the annual meeting, the
Supervisory Board has the power to limit or eliminate such rights. Such an
authorization may be effective for up to five years and may be renewed for
successive five-year periods. In connection with our initial public offering in
September 1995, our shareholders authorized the Supervisory Board to limit or
eliminate the preemptive rights of holders of our common shares for a five-year
period. At each annual meeting subsequent to 1995, our shareholders have
extended this period such that the current period is set to expire on May 29,
2007.
At the annual meeting, our shareholders will be asked to approve a further
extension of this authority for a five-year period from the date of the annual
meeting until May 22, 2008 to limit or eliminate preemptive rights. PREEMPTIVE
RIGHTS ARE UNCOMMON FOR PUBLIC COMPANIES DOMICILED IN THE UNITED STATES.
Management believes that if the Supervisory Board is not granted the authority
to limit preemptive rights, the ability of our company to engage in equity
financing transactions would be significantly affected. Furthermore, as long as
our common shares remain listed on the NYSE, any issuance of common shares will
remain subject to the rules of the NYSE, including limitations on our ability to
issue shares without shareholder approval. See Item 4 above for a discussion of
the NYSE rules regarding stock issuances.
The affirmative vote of the majority of the votes cast at the annual
meeting is required to extend the authority of the Supervisory Board to limit or
eliminate the preemptive rights of holders of our common shares for a five-year
period from the date of the annual meeting.
THE SUPERVISORY BOARD RECOMMENDS THAT SHAREHOLDERS VOTE "FOR" THE EXTENSION
OF THE AUTHORITY OF THE SUPERVISORY BOARD TO LIMIT OR ELIMINATE PREEMPTIVE
RIGHTS OF HOLDERS OF OUR COMMON SHARES UNTIL MAY 22, 2008, AND PROXIES EXECUTED
AND RETURNED WILL BE SO VOTED UNLESS CONTRARY INSTRUCTIONS ARE INDICATED
THEREON.
ITEM 6
RATIFICATION OF APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP
AS INDEPENDENT PUBLIC ACCOUNTANTS OF THE COMPANY FOR 2003
The Supervisory Board has appointed the firm of PricewaterhouseCoopers LLP
as our independent public accountants for the year ending December 31, 2003
subject to ratification by our shareholders. PricewaterhouseCoopers LLP has
acted as our independent public accountants since April 2002.
18
The affirmative vote of the majority of the votes cast at the annual
meeting is required to ratify the appointment of PricewaterhouseCoopers LLP as
our independent public accountants for 2003.
In the event the appointment is not ratified, our Supervisory Board will
consider the appointment of other independent accountants. Our Supervisory Board
may terminate the appointment of PricewaterhouseCoopers LLP as our independent
accountants without the approval of our shareholders whenever our Supervisory
Board deems such termination necessary or appropriate. Representatives of
PricewaterhouseCoopers LLP are not expected to be present at the annual meeting.
THE SUPERVISORY BOARD RECOMMENDS THAT THE SHAREHOLDERS VOTE "FOR" THE
RATIFICATION OF PRICEWATERHOUSECOOPERS' APPOINTMENT AS OUR INDEPENDENT PUBLIC
ACCOUNTANTS FOR 2003 AND PROXIES EXECUTED AND RETURNED WILL BE SO VOTED UNLESS
CONTRARY INSTRUCTIONS ARE INDICATED THEREON.
ITEM 7
OTHER MATTERS
The Supervisory Board does not know of any other matters that are to be
presented for action at the annual meeting. However, if any other matters
properly come before the annual meeting or any adjournment thereof, it is
intended that the enclosed proxy will be voted in accordance with the judgment
of the persons voting the proxy.
SHAREHOLDER PROPOSALS
Any shareholder who desires to submit a proposal for inclusion in the proxy
material for presentation at the 2004 annual meeting of shareholders must
forward such proposal to our corporate Secretary at the address indicated on the
cover page of this proxy statement, so that the Secretary receives it no later
than January 11, 2004. Any notice of a proposal to be considered at the 2004
annual meeting should also be submitted to our corporate Secretary. Any such
notice will be considered untimely if not received by the Secretary on or before
March 16, 2004.
By Order of the Board of Supervisory
Directors,
-s- Jacobus Schouten
JACOBUS SCHOUTEN
Supervisory Director
Amsterdam, The Netherlands
April 30, 2003
19
CORE LABORATORIES N.V.
THIS PROXY IS BEING SOLICITED ON BEHALF OF THE BOARD OF SUPERVISORY
DIRECTORS OF CORE LABORATORIES N.V. FOR THE ANNUAL MEETING OF SHAREHOLDERS TO BE
HELD ON FRIDAY, MAY 23, 2003.
P The undersigned hereby constitutes and appoints Jacobus Schouten and John D.
Denson, and each or either of them, his true and lawful attorneys and
proxies with full power of substitution, for and in the name, place and
R stead of the undersigned, to attend the Annual Meeting of Shareholders of
Core Laboratories N.V. to be held at the law offices of Nauta Dutilh,
Prinses Irenestraat 59, 1077 WV Amsterdam, The Netherlands, on Friday, May
O 23, 2003 at 10:00 a.m., local time, and any adjournment(s) thereof, with all
powers the undersigned would possess if personally present and to vote
thereof, as provided on the reverse side of this card, the number of shares
X the undersigned would be entitled to vote if personally present. In
accordance with their discretion, said attorneys and proxies are authorized
to vote upon such other matters and issues as may properly come before the
Y meeting or any adjournment thereof.
THIS PROXY IS BEING SOLICITED ON BEHALF OF THE BOARD OF SUPERVISORY DIRECTORS.
THIS PROXY WILL BE VOTED AS DIRECTED. IN THE ABSENCE OF DIRECTION, THIS PROXY
WILL BE VOTED FOR THE TWO NOMINEES FOR SUPERVISORY DIRECTOR AND FOR PROPOSALS
2, 3, 4, 5 AND 6.
(To be signed and continued on the reverse side.)
[X] Please mark your
vote as in this
example.
FOR WITHHELD Supervisory Directors
recommend a vote for
the election of the
following Supervisory
Directors:
1. Election of Supervisory Directors. [ ] [ ] Nominees:
Richard L. Bergmark
Alexander Vriesendorp
For, except vote withheld from the following nominee:
-----------------------------
2. Approval of Annual Accounts. FOR AGAINST ABSTAIN
[ ] [ ] [ ]
3. Approval of extension of authority of FOR AGAINST ABSTAIN
Management Board to repurchase up to 10% [ ] [ ] [ ]
of the outstanding share capital of the
Company until November 22, 2004.
4. Approval of extension of authority of FOR AGAINST ABSTAIN
Supervisory Board to issue and/or to [ ] [ ] [ ]
grant rights (including options to
purchase) with respect to our common
and/or preference shares until May 22,
2008.
FOR AGAINST ABSTAIN
5. Approval of extension of authority of [ ] [ ] [ ]
Supervisory Board to limit or eliminate
preemptive rights of holders of common
shares until May 22, 2008.
FOR AGAINST ABSTAIN
6. Ratification of appointment of [ ] [ ] [ ]
PricewaterhouseCoopers LLP as the
Company's independent public accountants
for the year ended December 31, 2003.
NOTE: SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENT
THEREOF SHALL BE VOTED IN ACCORDANCE WITH THE DISCRETION OF THE ATTORNEYS AND
PROXIES APPOINTED HEREBY.
SIGNATURE: DATE:
------------------------------ ------------------------------
SIGNATURE: DATE:
------------------------------ ------------------------------
NOTE: Please sign exactly as the name appears thereon. Joint owners should each sign. When
signing as attorney, executor, administrator, trustee or guardian, please give full
title as such.